1
|
Matsumaru T, Sueyoshi K, Okubo K, Fujii S, Sakuratani K, Saito R, Ueki K, Yamasaki S, Fujimoto Y. Trehalose diesters containing a polar functional group-modified lipid moiety: Synthesis and evaluation of Mincle-mediated signaling activity. Bioorg Med Chem 2022; 75:117045. [PMID: 36327694 DOI: 10.1016/j.bmc.2022.117045] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 08/31/2022] [Revised: 09/30/2022] [Accepted: 09/30/2022] [Indexed: 11/23/2022]
Abstract
Mincle, a C-type lectin receptor (CLR), activates the innate immune system by recognizing certain complex lipid compounds. In this study, we designed and synthesized trehalose disteate (TDS) and dibehenate (TDB), containing a polar-functional group in the middle of fatty acid moieties, based on a model of the Mincle-glycolipids interaction. The modified fatty acids were prepared using hydroxy fatty acids as common intermediates, and conjugated with an appropriate trehalose moiety to synthesize the desired trehalose diesters. TDE derivatives containing the modified fatty acid have different Mincle-mediated signaling activities depending on the position of the functional group and the length of the lipids. The newly developed TDE derivatives exhibit signaling activity comparable or superior to that of TDS or TDB, and the results suggest that Mincle tolerates polar functional groups at a certain position of the lipid chain of TDE. The introduction of the polar functional groups into the lipid moiety of the glycolipids also resulted in improved solubility in polar solvents, which would be advantageous for various analyses and applications.
Collapse
Affiliation(s)
- Takanori Matsumaru
- Faculty of Science and Technology, Keio University. Hiyoshi 3-14-1, Yokohama, Kanagawa 223-8522, Japan
| | - Kodai Sueyoshi
- Faculty of Science and Technology, Keio University. Hiyoshi 3-14-1, Yokohama, Kanagawa 223-8522, Japan
| | - Kana Okubo
- Faculty of Science and Technology, Keio University. Hiyoshi 3-14-1, Yokohama, Kanagawa 223-8522, Japan
| | - Shusuke Fujii
- Faculty of Science and Technology, Keio University. Hiyoshi 3-14-1, Yokohama, Kanagawa 223-8522, Japan
| | - Kasumi Sakuratani
- Faculty of Science and Technology, Keio University. Hiyoshi 3-14-1, Yokohama, Kanagawa 223-8522, Japan
| | - Ryota Saito
- Faculty of Science and Technology, Keio University. Hiyoshi 3-14-1, Yokohama, Kanagawa 223-8522, Japan
| | - Kazunari Ueki
- Faculty of Science and Technology, Keio University. Hiyoshi 3-14-1, Yokohama, Kanagawa 223-8522, Japan
| | - Sho Yamasaki
- Department of Molecular Immunology, Research Institute for Microbial Diseases, Osaka University, Suita 565-0871, Japan; Laboratory of Molecular Immunology, Immunology Frontier Research Center (WPI-IFReC), Osaka University, Suita 565-0871, Japan; Division of Molecular Design, Medical Institute of Bioregulation, Kyushu University, Fukuoka 812-8582, Japan; Division of Molecular Immunology, Medical Mycology Research Center, Chiba University, Chiba 260-8673, Japan
| | - Yukari Fujimoto
- Faculty of Science and Technology, Keio University. Hiyoshi 3-14-1, Yokohama, Kanagawa 223-8522, Japan.
| |
Collapse
|